The effect of vitamin A supplementation on the intestinal immune response in Mexican children is modified by pathogen infections and diarrhea.
Vitamin A supplementation has consistently reduced infant mortality and the severity of pathogen-induced diarrhea. The mechanism by which vitamin A modulates the mucosal immune response to produce these effects remains poorly defined. To address this issue, stools collected during the summer months from 127 Mexican children 5-15 mo old enrolled in a larger, randomized, double-blind, placebo-controlled, vitamin A supplementation trial were screened for interleukin (IL)-4, IL-6, interferon-gamma (IFN-gamma), and gastrointestinal pathogens. Fecal cytokine values were categorized into 3 levels (undetectable, <median, > or =median). Multinomial regression models were used to determine the probability that vitamin A-supplemented children had higher categorical values of a cytokine than children in the placebo group. Differences in categorical values were also analyzed after stratification by gastrointestinal pathogen infections and diarrheal symptoms. Overall, fecal cytokine categorical levels did not differ between children randomized to the 2 arms. Vitamin A-supplemented children infected with enteropathogenic E. coli (EPEC) had reduced IL-4 and IFN-gamma levels [odds ratio (OR) = 0.3, 95% CI 0.13-0.67 and OR = 0.34, 95% CI 0.14-0.83, respectively] compared with children in the placebo group. Vitamin A-supplemented children had increased IL-4 levels when infected with A. lumbricoides (OR = 12.06, 95% CI 0.95-153.85). In contrast, IL-4 levels increased (OR = 2.14, 95% CI 0.94-4.87) and IFN-gamma levels decreased (OR = 0.51, 95% CI 0.26-0.99) among vitamin A-supplemented children with diarrhea compared with children in the placebo group. These findings suggest that the regulation of the mucosal immune response by vitamin A may depend on the type of enteric pathogen infecting the child and the presence of clinical symptoms.
Long
Kurt Z
KZ
Department of Nutrition, Harvard School of Public Health, Boston, MA, USA. klong@hsph.harvard.edu
Estrada-Garcia
Teresa
T
Rosado
Jorge L
JL
Ignacio Santos
Jose
J
Haas
Meredith
M
Firestone
Mathew
M
Bhagwat
Jui
J
Young
Cheryl
C
DuPont
Herbert L
HL
Hertzmark
Ellen
E
Nanthakumar
Nanda N
NN
D000818:Animals; D001196:Ascariasis / Q000276:immunology; D001200:Ascaris / Q000302:isolation & purification; D001827:Body Height; D001835:Body Weight; D003140:Communicable Disease Control; D003967:Diarrhea / Q000276:immunology* / Q000469:parasitology; D019587:Dietary Supplements; D005243:Feces / Q000469:parasitology; D005260:Female; D006801:Humans; D018928:Immunity, Mucosal / Q000187:drug effects*; D007223:Infant; D008297:Male; D008800:Mexico; D012959:Socioeconomic Factors; D018417:Th1 Cells / Q000382:microbiology; D018418:Th2 Cells / Q000276:immunology; D014801:Vitamin A / Q000494:pharmacology*
D014801:Vitamin A